The Oncology Institute, Inc. (TOI)

NASDAQ: TOI · Real-Time Price · USD

1.480

+0.220 (17.46%)

At close: Apr 2, 2025, 4:00 PM

1.470

-0.010 (-0.68%)

After-hours: Apr 2, 2025, 4:38 PM EDT

The Oncology Institute Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Revenue	393.41	324.24	252.48	203	187.52	Upgrade
Revenue Growth (YoY)	21.33%	28.42%	24.37%	8.26%	20.66%	Upgrade
Cost of Revenue	339.42	264.67	200.39	162.16	150.64	Upgrade
Gross Profit	54	59.57	52.09	40.85	36.88	Upgrade
Selling, General & Admin	107.83	113.85	119.69	82.89	41.52	Upgrade
Operating Expenses	114.12	119.72	124.1	86.23	44.7	Upgrade
Operating Income	-60.12	-60.15	-72.01	-45.38	-7.82	Upgrade
Interest Expense	-7.5	-6.78	-4.08	-0.32	-0.35	Upgrade
Other Non Operating Income (Expenses)	2.82	-0.35	25.9	3.71	-8.72	Upgrade
EBT Excluding Unusual Items	-64.8	-67.28	-50.19	-41.99	-16.89	Upgrade
Merger & Restructuring Charges	-	-	-	-0.48	1.1	Upgrade
Impairment of Goodwill	-	-16.87	-9.94	-	-	Upgrade
Gain (Loss) on Sale of Investments	0.13	0.24	0.64	-	-	Upgrade
Other Unusual Items	-	0.8	59.4	30.87	0.98	Upgrade
Pretax Income	-64.66	-83.1	-0.09	-11.6	-14.82	Upgrade
Income Tax Expense	-	-0.04	-0.24	-0.67	-0.49	Upgrade
Net Income	-64.66	-83.07	0.15	-10.93	-14.32	Upgrade
Preferred Dividends & Other Adjustments	-11.66	-15.19	0.08	-0.3	-	Upgrade
Net Income to Common	-53.01	-67.88	0.07	-10.63	-14.32	Upgrade
Shares Outstanding (Basic)	75	74	73	66	59	Upgrade
Shares Outstanding (Diluted)	75	74	81	66	59	Upgrade
Shares Change (YoY)	1.76%	-8.51%	21.70%	12.03%	-	Upgrade
EPS (Basic)	-0.71	-0.92	0.00	-0.16	-0.24	Upgrade
EPS (Diluted)	-0.71	-0.92	-0.21	-0.16	-0.24	Upgrade
Free Cash Flow	-30.33	-40.88	-67.29	-35.53	-0.69	Upgrade
Free Cash Flow Per Share	-0.40	-0.55	-0.83	-0.54	-0.01	Upgrade
Gross Margin	13.73%	18.37%	20.63%	20.12%	19.67%	Upgrade
Operating Margin	-15.28%	-18.55%	-28.52%	-22.36%	-4.17%	Upgrade
Profit Margin	-13.47%	-20.93%	0.03%	-5.24%	-7.64%	Upgrade
Free Cash Flow Margin	-7.71%	-12.61%	-26.65%	-17.50%	-0.37%	Upgrade
EBITDA	-53.83	-54.28	-67.6	-42.04	-4.65	Upgrade
EBITDA Margin	-13.68%	-16.74%	-26.77%	-20.71%	-2.48%	Upgrade
D&A For EBITDA	6.29	5.87	4.41	3.34	3.18	Upgrade
EBIT	-60.12	-60.15	-72.01	-45.38	-7.82	Upgrade
EBIT Margin	-15.28%	-18.55%	-28.52%	-22.36%	-4.17%	Upgrade
Revenue as Reported	393.41	324.24	252.48	203	187.52	Upgrade

Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q